Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis

MLA

Gerd Horneff, et al. “Re-Treatment with Etanercept Is as Effective as the Initial Firstline Treatment in Patients with Juvenile Idiopathic Arthritis.” Arthritis Research & Therapy, vol. 23, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....423fab9b53bbc1cce4f51a7b6cb466d7&authtype=sso&custid=ns315887.

APA

Gerd Horneff, Daniel Windschall, Ivan Foeldvari, Kirsten Minden, Paula Hoff, Johannes-Peter Haas, Ariane Klein, Jens Klotsche, & Martina Niewerth. (2021). Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis. Arthritis Research & Therapy, 23.

Chicago

Gerd Horneff, Daniel Windschall, Ivan Foeldvari, Kirsten Minden, Paula Hoff, Johannes-Peter Haas, Ariane Klein, Jens Klotsche, and Martina Niewerth. 2021. “Re-Treatment with Etanercept Is as Effective as the Initial Firstline Treatment in Patients with Juvenile Idiopathic Arthritis.” Arthritis Research & Therapy 23 (April). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....423fab9b53bbc1cce4f51a7b6cb466d7&authtype=sso&custid=ns315887.